Last June, Seoul’s Ministry of Food and Drug Safety said that research they conducted had indicated that HnB devices contain up to five cancer-causing substances and that the level of tar discovered in two of the products, including Philip Morris’ iQOS, is higher than the level found in cigarettes. Subsequently, Philip Morris had asked to look at the data from this study, but the ministry refused to share it, which led to the tobacco company’s decision to sue.

Independent studies indicating the relative safety of HnB

The claims made by the ministry are in contrast with research from around the world, including independent studies by several public health experts. A study by renowned anti-smoking expert Dr Konstantinos Farsalinos, which compared carbonyl emissions from iQOS, an e-cigarette and a regular cigarette, concluded that the device is safer than regular cigarettes.

Another study conducted by the independent Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (COT), reviewed two “heat-not-burn” tobacco products, PMI’s IQOS and British American Tobacco’s iFuse.

The data gathered by the committee indicated that the products still pose a risk. However added the COT, despite not being able to quantify the exact level, this risk is still lower than the one from smoking.

HnBs are not fully risk free but relatively safer than cigarettes

“The evidence suggests that heat-not-burn products still pose a risk to users,” said COT chairman Professor Alan Boobis. “There is likely to be a reduction in risk for cigarette smokers who switch to heat-not-burn products but quitting entirely would be more beneficial.”

Read Further: Euronews

PMI Says that iQOS can Reduce Prevalence of Lung Carcinomas

Previous articleThe WHO is Criticized for Endorsing Countries Which Ban E-Cigarettes
Next articlePMI: Dialogue Needed Between the Industry & Health and Policy Experts
In-house journalist covering international vaping news.